Medical Journal with an impact-Oncotarget

Cancer has been an epidemic disease affecting thousands of people across the world. Researchers, as well as a medical experts, have been carrying out different studies and research to determine the course as well as the best treatment for the diseases. These researchers have led to the foundation of a journal known as Oncotarget which has become popular to not only the medical experts and scientific research hers but also to the individuals who are affected as well as infected by the disease; cancer. The medical journal published in English, the publishing is done on a weekly basis and it is free for the purpose of quick access.

Oncotarget was first published in 2010 by Impact Journal. Since its foundation it has been expanding tremendously with it being published in other media platforms including; Face book, Twitter, Google, as well as Dove Press. Nevertheless, the journal does not only deal with cancer and oncology but it has also expanded its studies to other areas including aging among others. Since its creation, it has grown to be the most famous scientific and medical paper in the world. Oncotarget is led by top research hers in the world and has the most experienced chief editors who include; Mikhail Blagosklonny, and Andrei V. Gudkov who are both professors at Roswell Park Cancer Institute.

Oncotarget was primarily founded with the purpose of delivering scientific research without any obstacle between various medical fields. It does not only researchers and publishes mainly on cancer as well as other medical fields which cancer affect. Over the years the Oncotarget management has been encouraging their publishers to expand their articles and study on other medical areas including; metabolism, microbiology, aging, neuroscience, pharmacology, molecular biology, and cardiology. The editors, as well as publishers, are advised to use strict rules and regulations which are set by COPE’s. The journal is publicly available to the world this has assisted cancer patients as well as their families to read and have knowledge on the diseases. The publisher’s articles have to go through a before it is published on Oncotarget site. The articles have to go through the editors and finally the chief editors who make the final decision about the article. The good thing about Oncotarget is that the scientists can view their work and how far it has gone before it is published. Over the years it has been known to be most efficient medical journal across the world.

The A-Z about Oncotarget

Oncotarget is a traditional journal with a different discipline. Individuals can access the Journal free online. They publish their journals in weekly issues and allow individuals to print weekly issues or papers on demand. Oncotarget have achieved numerous success, which has prompted them to launch sections beyond oncology. They specialize in aging, autophagy, oncology, immunology, pathology, neuroscience, cell death, neurotarget, and Circadian Rhythm. The Journal has employed 11-50 people.

Their mission

  • To make scientific results readily and rapidly available for everyone
  • To offer insight reviews that maximize the impact of research
  • To allow exceptional discoveries to be shared with the public efficiently
  • To end the borders between different specialties and link various biomedical science fields
  • To encourage applications of standard and clinical medicine to help in fight off disease and assist in building a life with no diseases
  • Through the experience and skills of most prominent specialists, oncotarget allows all researchers to take part in the progress of science. Follow Oncotarget on Twitter.

The advantages of publishing in ontotarget

They are a public journal, which means that any paper will be made available to anyone around the world and they can download and print it from the website. Despite receiving a significant number of papers, they will still publish your article. Compared to other traditional journals they offer ample space due to their new electronic system, which enables them to publish papers without limits.They can post as many articles as they want.

It is common knowledge that most journals take a long time to review papers after they have been submitted which is frustrating to the authors. However, at Oncotarget this is not the case. They have one of the fastest modes to review your papers around the world. Mostly, their analysis takes around two weeks, and the editor decision will be made in less than a week of this. Therefore, authors do not have to wait for a month for the final determination.

Reviews from other authors have shown that Oncotargets reviewer comments have added the value of their papers. In conclusion, Oncotarget is one of the leading journals in the world today.